The global flow cytometry market size is expected to reach USD 12.29 billion by 2028 according to a new study by Polaris Market Research. The report “Flow Cytometry Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology (Cell-based, Bead-based), By Application (Research, Industrial, Clinical), By End-Use, By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Over the forecast period, the high incidence of chronic diseases, the launch of technically advanced flow cytometry solutions, and rising R&D investments in the pharma companies are anticipated to accelerate market development. Also, the rising incidence of cancer, autoimmune disease abnormalities, and contagious diseases, such as the COVID-19 outbreak, has boosted the demand for flow cytometry solutions in clinical and research settings.
According to the American Cancer Society, approximately 1.8 million new cases of cancer were reported in the U.S. market in 2020. Moreover, as per the National Cancer Institute (NCI), there were approximately 16.9 million cancer sufferers in the U.S., as of January 2019.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/flow-cytometry-market/request-for-sample
Growing regulatory approval and the launch of technically advanced flow cytometry technologies are expected to aid market development of flow cytometry. Sysmex Corporation, for example, unveiled the XF-1600 cytometers for laboratories in the U.S., in June 2020.
Besides, Beckman, a Danaher Corporation company, expanded its portfolio of offerings, in January 2019, with the introduction of its latest ClearLLab 10C System. It is an integrated solution that offers a streamlined workflow that ensures consistency and reliability in clinical results.
Future market growth opportunities in flow cytometry solutions are expected to be provided by technological advances that result in increased accuracy, and cost-effectiveness. Miniaturized high-throughput cytometers are expected to gain market popularity shortly.
Rapid market advancement in multi-color flow cytometry, which has a wide range of applications in novel drug formulations, have made it possible to perform a cell analysis by evaluating several parameters at the same time. Many contract research companies use these instruments extensively.
Market participants such as Danaher Corporation, Sysmex Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., EMD Millipore, Miltenyi Biotec, Inc. Becton, Dickinson and Company, Affymetix Inc., Thermo Fischer Scientific, and Agilent Technologies, Inc. are some of the leading players operating in the market for flow cytometry.
Polaris Market Research has segmented the flow cytometry market report based on product, technology, application, end-use, and region:
Flow Cytometry, Product Outlook (Revenue – USD Billion, 2016 – 2028)
- Reagents & Consumables
Flow Cytometry, Technology Outlook (Revenue – USD Billion, 2016 – 2028)
Flow Cytometry, Application Outlook (Revenue – USD Billion, 2016 – 2028)
Flow Cytometry, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)
- Commercial Organizations
- Academic Institutes
- Clinical Testing Labs
Flow Cytometry, Regional Outlook (Revenue – USD Billion, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa